Public health advisory on the proper use of Tussionex
The FDA issued an public health advisory today regarding the safe and correct us of Tussionex Pennkinetic Extended-Release Suspension. The alert follows numerous reports of serious problems - including death - associated with the misuse of this medication. Tussionex is a prescription cough medicine containing hydrocodone, a narcotic ingredient, and the antihistamine chlorpheniramine. The product is approved for use in adults and children over the age of six years old, and should be given no more frequently than every 12 hours ("extended-release"). Too much hydrocodone, particularly when used in combination with chlorpheniramine, can cause life-threatening breathing problems and death. The alert emphasizes that patients SHOULD NOT take this medication more frequently than every 12 hours, and SHOULD NOT take more than the recommended dose. It also emphasizes that this medication SHOULD NOT be used in children less than 6 years old, for whom this medication is not approved. For more information, please visit: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm107208.htm
Learn More

Public health advisory on the proper use of Tussionex
The FDA issued an public health advisory today regarding the safe and correct us of Tussionex Pennkinetic Extended-Release Suspension. The alert follows numerous reports of serious problems - including death - associated with the misuse of this medication. Tussionex is a prescription cough medicine containing hydrocodone, a narcotic ingredient, and the antihistamine chlorpheniramine. The product is approved for use in adults and children over the age of six years old, and should be given no more frequently than every 12 hours ("extended-release"). Too much hydrocodone, particularly when used in combination with chlorpheniramine, can cause life-threatening breathing problems and death. The alert emphasizes that patients SHOULD NOT take this medication more frequently than every 12 hours, and SHOULD NOT take more than the recommended dose. It also emphasizes that this medication SHOULD NOT be used in children less than 6 years old, for whom this medication is not approved. For more information, please visit: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm107208.htm
Learn More